Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Maverix Private Equity is a Toronto-based growth equity firm that invests in North American companies within the healthcare, technology, and consumer sectors. Founded by prominent Canadian investors John Ruffolo and Mark Wiseman, the firm targets businesses undergoing significant disruption or transformation that have proven business models and clear paths to scale. In the healthcare space, Maverix focuses on technology-enabled services and innovative health-tech solutions that improve patient outcomes and operational efficiency. The firm provides strategic capital, operational expertise, and a broad network to help its portfolio companies achieve global leadership.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Maverix Private Equity.